Litigation Details for Gilead Sciences, Inc. v. Merck & Co., Inc. (Fed. Cir. 2016)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Merck & Co., Inc. (Fed. Cir. 2016)
| Docket | See Plans and Pricing | Date Filed | 2016-07-06 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2018-04-25 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,043,230; 7,034,007; 9,022,022 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Merck & Co., Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Biologic Drugs cited in Gilead Sciences, Inc. v. Merck & Co., Inc.
The biologic drug covered by the patents cited in this case is See Plans and Pricing .
Details for Gilead Sciences, Inc. v. Merck & Co., Inc. (Fed. Cir. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-11-28 | 47 | disclosed U.S. Pat. Nos. 5,922,695; 5,977,089; 6,043,230; 55 and 6,069,249, the contents of each…disclosed U.S. Pat. Nos. 5,922,695; 5,977,0S9; 6,043,230; washed with 5% NaHC0 3 in water (75 mL) and brine…Merck’s patents, U.S. Patent No. 7,105,499 (’499 patent) and U.S. Patent No. 8,481,712 (’712 patent). After…engage in that patent-by-patent analysis here. It had no power to bar the ’712 patent’s enforcement on…Merck asserts that two of its patents, U.S. Patent No. 7,105,499 and U.S. Patent No. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
